101 related articles for article (PubMed ID: 9010913)
1. Antisense DNA toward type I protein kinase A produces sustained inhibition of tumor growth.
Cho-Chung YS
Proc Assoc Am Physicians; 1997 Jan; 109(1):23-32. PubMed ID: 9010913
[TBL] [Abstract][Full Text] [Related]
2. Protein kinase A-directed antisense restrains cancer growth: sequence-specific inhibition of gene expression.
Cho-Chung YS
Antisense Nucleic Acid Drug Dev; 1996; 6(3):237-44. PubMed ID: 8915509
[TBL] [Abstract][Full Text] [Related]
3. Oligonucleotide sequence-specific inhibition of gene expression, tumor growth inhibition, and modulation of cAMP signaling by an RNA-DNA hybrid antisense targeted to protein kinase A RIalpha subunit.
Nesterova M; Cho-Chung YS
Antisense Nucleic Acid Drug Dev; 2000 Dec; 10(6):423-33. PubMed ID: 11198926
[TBL] [Abstract][Full Text] [Related]
4. Antisense DNA-targeting protein kinase A-RIA subunit: a novel approach to cancer treatment.
Cho-Chung YS; Nesterova M; Pepe S; Lee GR; Noguchi K; Srivastava RK; Srivastava AR; Alper O; Park YG; Lee YN
Front Biosci; 1999 Dec; 4():D898-907. PubMed ID: 10577386
[TBL] [Abstract][Full Text] [Related]
5. Dissecting the circuitry of protein kinase A and cAMP signaling in cancer genesis: antisense, microarray, gene overexpression, and transcription factor decoy.
Cho-Chung YS; Nesterova M; Becker KG; Srivastava R; Park YG; Lee YN; Cho YS; Kim MK; Neary C; Cheadle C
Ann N Y Acad Sci; 2002 Jun; 968():22-36. PubMed ID: 12119265
[TBL] [Abstract][Full Text] [Related]
6. Compensatory stabilization of RIIbeta protein, cell cycle deregulation, and growth arrest in colon and prostate carcinoma cells by antisense-directed down-regulation of protein kinase A RIalpha protein.
Nesterova M; Noguchi K; Park YG; Lee YN; Cho-Chung YS
Clin Cancer Res; 2000 Sep; 6(9):3434-41. PubMed ID: 10999726
[TBL] [Abstract][Full Text] [Related]
7. A single-injection protein kinase A-directed antisense treatment to inhibit tumour growth.
Nesterova M; Cho-Chung YS
Nat Med; 1995 Jun; 1(6):528-33. PubMed ID: 7585118
[TBL] [Abstract][Full Text] [Related]
8. Differentiation of HL-60 leukemia by type I regulatory subunit antisense oligodeoxynucleotide of cAMP-dependent protein kinase.
Tortora G; Yokozaki H; Pepe S; Clair T; Cho-Chung YS
Proc Natl Acad Sci U S A; 1991 Mar; 88(5):2011-5. PubMed ID: 2000408
[TBL] [Abstract][Full Text] [Related]
9. Retroviral vector-mediated overexpression of the RII beta subunit of the cAMP-dependent protein kinase induces differentiation in human leukemia cells and reverts the transformed phenotype of mouse fibroblasts.
Tortora G; Budillon A; Yokozaki H; Clair T; Pepe S; Merlo G; Rohlff C; Cho-Chung YS
Cell Growth Differ; 1994 Jul; 5(7):753-9. PubMed ID: 7947390
[TBL] [Abstract][Full Text] [Related]
10. An antisense oligodeoxynucleotide that depletes RI alpha subunit of cyclic AMP-dependent protein kinase induces growth inhibition in human cancer cells.
Yokozaki H; Budillon A; Tortora G; Meissner S; Beaucage SL; Miki K; Cho-Chung YS
Cancer Res; 1993 Feb; 53(4):868-72. PubMed ID: 8428367
[TBL] [Abstract][Full Text] [Related]
11. Growth arrest and induction of apoptosis in breast cancer cells by antisense depletion of protein kinase A-RI alpha subunit: p53-independent mechanism of action.
Srivastava RK; Srivastava AR; Seth P; Agrawal S; Cho-Chung YS
Mol Cell Biochem; 1999 May; 195(1-2):25-36. PubMed ID: 10395066
[TBL] [Abstract][Full Text] [Related]
12. Anti-proliferative effects of 8-chloro-cAMP and other cAMP analogs are unrelated to their effects on protein kinase A regulatory subunit expression.
Lamb D; Steinberg RA
J Cell Physiol; 2002 Aug; 192(2):216-24. PubMed ID: 12115728
[TBL] [Abstract][Full Text] [Related]
13. Experimental gene therapy of human colon cancer.
Bold RJ; Warren RE; Ishizuka J; Cho-Chung YS; Townsend CM; Thompson JC
Surgery; 1994 Aug; 116(2):189-95; discussion 195-6. PubMed ID: 8047985
[TBL] [Abstract][Full Text] [Related]
14. Cyclic AMP-dependent protein kinase isoenzymes in human myeloid leukemia (HL60) and breast tumor (MCF-7) cells.
Taimi M; Breitman TR; Takahashi N
Arch Biochem Biophys; 2001 Aug; 392(1):137-44. PubMed ID: 11469804
[TBL] [Abstract][Full Text] [Related]
15. Tumor reversion: protein kinase A isozyme switching.
Cho-Chung YS; Nesterova MV
Ann N Y Acad Sci; 2005 Nov; 1058():76-86. PubMed ID: 16394127
[TBL] [Abstract][Full Text] [Related]
16. 8-Chloroadenosine mediates 8-chloro-cyclic AMP-induced down-regulation of cyclic AMP-dependent protein kinase in normal and neoplastic mouse lung epithelial cells by a cyclic AMP-independent mechanism.
Lange-Carter CA; Vuillequez JJ; Malkinson AM
Cancer Res; 1993 Jan; 53(2):393-400. PubMed ID: 8380255
[TBL] [Abstract][Full Text] [Related]
17. Chemoprevention with protein kinase A RIalpha antisense in DMBA-mammary carcinogenesis.
Nesterova MV; Cho-Chung YS
Ann N Y Acad Sci; 2005 Nov; 1058():255-64. PubMed ID: 16394142
[TBL] [Abstract][Full Text] [Related]
18. Antisense protein kinase A RIalpha inhibits 7,12-dimethylbenz(a)anthracene-induction of mammary cancer: blockade at the initial phase of carcinogenesis.
Nesterova MV; Cho-Chung YS
Clin Cancer Res; 2004 Jul; 10(13):4568-77. PubMed ID: 15240549
[TBL] [Abstract][Full Text] [Related]
19. Type II protein kinase A up-regulation is sufficient to induce growth inhibition in SK-N-SH human neuroblastoma cells.
Kim SN; Lee GR; Hwang ES; Lee JH; Park SD; Cho-Chung YS; Hong SH
Biochem Biophys Res Commun; 1997 Mar; 232(2):469-73. PubMed ID: 9125203
[TBL] [Abstract][Full Text] [Related]
20. Down-regulation of type I protein kinase A by transfection of human breast cancer cells with an epidermal growth factor receptor antisense expression vector.
Ciardiello F; Dixit M; di Isernia G; Damiano V; Bianco R; Bianco AR; Arteaga CL; Tortora G
Breast Cancer Res Treat; 1998 Jan; 47(1):57-62. PubMed ID: 9493976
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
